New incident report
Incident Report Number: 2023-4158
Registrant Reference Number: 2023-CA-000218
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: CANADA
Prov / State: ONTARIO
PMRA Registration No. 29930 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard OneSpot Flea and Tick Cat Drops
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Medical Professional
Cat / Chat
Domestic Shorthair
1
Unknown
4
7.0
kg
Skin
Unknown / Inconnu
<=30 min / <=30 min
System
Unknown / Inconnu
Yes
No
Unknown/Inconnu
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 08-Jun-2023, a 4 year old, approximately 7.0 kilogram, Domestic Shorthair cat, of unknown further signalment, in unknown condition, with no known concomitant medical condition, was administered 1 tube of Hartz UltraGuard OneSpot Flea and Tick Cat Drops (S Methoprene) via the topical route by the animal owner. Immediately post-application, the cat developed application site itching (pruritus). On approximately 09-Jun-2023, the cat developed application site hair loss from self trauma, application site redness, application site sores, application site scabs, application site chemical burn and was unable to sleep. On 15-Jun-2023, the event was reported by the treating veterinarian and the signs continued. The cat was prescribed an unknown dose of prednisone to be given to the cat by the animal owner, at a tapering dose for 7 days. Bathing the cat with liquid soap was also recommended to the owner by the veterinarian. It is unknown if the cat was actually bathed. On 16-Jun-2023, the clinical sign of being unable to sleep resolved. The application site itching and application site hair loss improved but continued. The remaining clinical symptoms continued. No further information was received.
Moderate
Assessment: S-methoprene has a very wide margin of safety in cats. Sores and burns are not anticipated simply from application of the product, but if a cat has been persistently scratching at a certain area, skin damage and an open sore may occur. However, hypersensitivity is possible with any topical product and may be related to either the product's active or inactive ingredients. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.